Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dietary Factors Limit Inflammation and Prevent Colon Cancer

By LabMedica International staff writers
Posted on 28 Aug 2018
A team of cancer researchers working with a mouse model has found that a chemical generated during digestion of vegetables such kale, cabbage, and broccoli activates a protein that helps maintain the integrity of the cells lining the gut – preventing chronic inflammation that has been implicated in the development of colon cancer.

The epithelium and immune compartment in the intestine are constantly exposed to a fluctuating external environment. More...
Defective communication between these compartments at this barrier surface underlies susceptibility to infections and chronic inflammation.

In this regard, investigators at the Francis Crick Institute (London, United Kingdom) found that generation of intestinal epithelial cells upon injury through infection or chemical insults was profoundly influenced by the environmental sensor aryl hydrocarbon receptor (AHR). This protein is a member of the family of basic helix-loop-helix transcription factors. AHR binds several exogenous ligands such as natural plant flavonoids, polyphenolics, and indoles, as well as synthetic polycyclic aromatic hydrocarbons and dioxin-like compounds.

The investigators reported in the August 14, 2018, online edition of the journal Immunity that mice receiving a diet rich in indole-3-carbinol (I3C), which is produced during digestion of vegetables of the genus Brassica, were protected from gut inflammation and colon cancer. Specific deletion of Ahr from intestinal epithelial cells resulted in failure to control Citrobacter rodentium infection due to unrestricted intestinal stem cell (ISC) proliferation and impaired differentiation, culminating in transformation into cancer cells. AHR activation by dietary ligands, such as I3C, restored barrier homeostasis, protected the stem cell niche, and prevented tumor formation.

"Seeing the profound effect of diet on gut inflammation and colon cancer was very striking," said senior author Dr. Gitta Stockinger, group leader at the Francis Crick Institute. "We often think of colon cancer as a disease promoted by a Western diet rich in fat and poor in vegetable content, and our results suggest a mechanism behind this observation. Many vegetables produce chemicals that keep AhR stimulated in the gut. We found that AhR-promoting chemicals in the diet can correct defects caused by insufficient AhR stimulation. This can restore epithelial cell differentiation, offering resistance to intestinal infections and preventing colon cancer. These findings are a cause for optimism; while we cannot change the genetic factors that increase our risk of cancer, we can probably mitigate these risks by adopting an appropriate diet with plenty of vegetables."

"A number of epidemiological studies suggested that vegetables may be protective against cancer," said Dr. Stockinger. "However, there is very little literature on which vegetables are the most beneficial or why. Now that we have demonstrated the mechanistic basis for this in mice, we are going to investigate these effects in human cells and people. In the meantime, there is certainly no harm in eating more vegetables!"

Related Links:
Francis Crick Institute


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.